Literature DB >> 12062884

Parietal dysfunction is associated with increased outcome-related decision-making in schizophrenia patients.

Martin P Paulus1, Nikki E Hozack, Blanca E Zauscher, Lawrence Frank, Gregory G Brown, Jennifer McDowell, David L Braff.   

Abstract

BACKGROUND: Decision-making is a complex process and depends on a network of fronto-parietal and cingulate areas. Decision-making dysfunctions in schizophrenia patients are characterized by an alternation between stereotypic and unpredictable responses. This study tested the hypothesis that schizophrenia patients show less decision-making-related activation in the prefrontal and parietal cortex.
METHODS: Fifteen schizophrenia patients were matched with fifteen normal comparison subjects. During functional magnetic resonance imaging (fMRI) scanning, subjects were tested on the two-choice prediction task (predicting the location of a randomly presented stimulus) and the two-choice response task (responding according to the location of the stimulus).
RESULTS: Schizophrenia patients relative to comparison subjects generated more outcome-dependent responses. Schizophrenia patients and normal comparison subjects showed decision-making-related activation in right prefrontal cortex, insula, anterior cingulate, and bilateral precuneus. Schizophrenia patients showed less activation in inferior, medial prefrontal, and right superior temporal cortex and more activation in the postcentral and inferior parietal cortex. Decision-making-related activation in both right prefrontal and bilateral parietal cortex was higher in medicated compared to unmedicated schizophrenia patients.
CONCLUSIONS: These results support the hypothesis that the interaction between prefrontal and parietal cortex during decision-making by schizophrenia patients is dysregulated, which results in an increased outcome-dependent response selection.

Entities:  

Mesh:

Year:  2002        PMID: 12062884     DOI: 10.1016/s0006-3223(01)01358-0

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  13 in total

1.  Abnormal responses to monetary outcomes in cortex, but not in the basal ganglia, in schizophrenia.

Authors:  James A Waltz; Julie B Schweitzer; Thomas J Ross; Pradeep K Kurup; Betty J Salmeron; Emma J Rose; James M Gold; Elliot A Stein
Journal:  Neuropsychopharmacology       Date:  2010-08-18       Impact factor: 7.853

2.  Impaired Activation in Cognitive Control Regions Predicts Reversal Learning in Schizophrenia.

Authors:  Adam J Culbreth; James M Gold; Roshan Cools; Deanna M Barch
Journal:  Schizophr Bull       Date:  2015-06-06       Impact factor: 9.306

3.  Common and distinct brain activity associated with risky and ambiguous decision-making.

Authors:  Ranjita Poudel; Michael C Riedel; Taylor Salo; Jessica S Flannery; Lauren D Hill-Bowen; Simon B Eickhoff; Angela R Laird; Matthew T Sutherland
Journal:  Drug Alcohol Depend       Date:  2020-02-04       Impact factor: 4.492

4.  Neuroanatomical substrates accounting for the effect of present hedonistic time perspective on risk preference: the mediating role of right posterior parietal cortex.

Authors:  Ting Xu; Zhiyi Chen; Fuschia M Sirois; Rong Zhang; Yaqi Yang; Tingyong Feng
Journal:  Brain Imaging Behav       Date:  2021-02       Impact factor: 3.978

5.  A brain-wide association study of DISC1 genetic variants reveals a relationship with the structure and functional connectivity of the precuneus in schizophrenia.

Authors:  Xiaohong Gong; Wenlian Lu; Keith M Kendrick; Weidan Pu; Chu Wang; Li Jin; Guangmin Lu; Zhening Liu; Haihong Liu; Jianfeng Feng
Journal:  Hum Brain Mapp       Date:  2014-06-07       Impact factor: 5.038

6.  Adults with autism show increased sensitivity to outcomes at low error rates during decision-making.

Authors:  Arpi Minassian; Martin Paulus; Alan Lincoln; William Perry
Journal:  J Autism Dev Disord       Date:  2006-11-01

Review 7.  Neuroeconomic approaches to mental disorders.

Authors:  Kenneth T Kishida; Brooks King-Casas; P Read Montague
Journal:  Neuron       Date:  2010-08-26       Impact factor: 17.173

8.  White matter alterations in schizophrenic patients with pronounced negative symptomatology and with positive family history for schizophrenia.

Authors:  Thomas Zetzsche; Ulrich W Preuss; Thomas Frodl; Gerda Leinsinger; Christine Born; Maximilian Reiser; Ulrich Hegerl; Hans-Jürgen Möller; Eva M Meisenzahl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-04-24       Impact factor: 5.270

9.  Clinical course of children and adolescents with bipolar spectrum disorders.

Authors:  Boris Birmaher; David Axelson; Michael Strober; Mary Kay Gill; Sylvia Valeri; Laurel Chiappetta; Neal Ryan; Henrietta Leonard; Jeffrey Hunt; Satish Iyengar; Martin Keller
Journal:  Arch Gen Psychiatry       Date:  2006-02

10.  Multifaceted genomic risk for brain function in schizophrenia.

Authors:  Jiayu Chen; Vince D Calhoun; Godfrey D Pearlson; Stefan Ehrlich; Jessica A Turner; Beng-Choon Ho; Thomas H Wassink; Andrew M Michael; Jingyu Liu
Journal:  Neuroimage       Date:  2012-03-13       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.